Dosimetric comparison of postoperative interstitial high-dose-rate brachytherapy and modern external beam radiotherapy modalities in tongue and floor of the mouth tumours in terms of doses to critical organs

1. Strnad V. Treatment of oral cavity and oropharyngeal cancer. Indications, technical aspects, and results of interstitial brachytherapy. Strahlenther Onkol 2004; 180: 710–17. doi: 10.1007/s00066-004-9196-x StrnadV Treatment of oral cavity and oropharyngeal cancer. Indications, technical aspects, and results of interstitial brachytherapy Strahlenther Onkol 2004 180 710 17 10.1007/s00066-004-9196-x Open DOISearch in Google Scholar

2. Ferenczi Ö, Major T, Akiyama H, Fröhlich G, Oberna F, Révész M, et al. Results of postoperative interstitial brachytherapy of resectable floor of mouth tumors. Brachytherapy 2021; 20: 376–82. doi: 10.1016/j.brachy.2020.10.008 FerencziÖ MajorT AkiyamaH FröhlichG ObernaF RévészM Results of postoperative interstitial brachytherapy of resectable floor of mouth tumors Brachytherapy 2021 20 376 82 10.1016/j.brachy.2020.10.008 Open DOISearch in Google Scholar

3. Kovács G, Martinez-Monge R, Budrukkar A, Jose Luis G, Bengt J, Vratislav S, et al. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update – Improvement by cross sectional imaging based treatment planning and stepping source technology. Radiother Oncol 2017; 122: 248–54. doi: 10.1016/j.radonc.2016.10.008 KovácsG Martinez-MongeR BudrukkarA Jose LuisG BengtJ VratislavS GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update – Improvement by cross sectional imaging based treatment planning and stepping source technology Radiother Oncol 2017 122 248 54 10.1016/j.radonc.2016.10.008 Open DOISearch in Google Scholar

4. Chinn SB, Myers JN. Oral cavity carcinoma: current management, controversies, and future directions. J Clin Oncol 2015; 33: 3269–76. doi: 10.1200/JCO.2015.61.2929 ChinnSB MyersJN Oral cavity carcinoma: current management, controversies, and future directions J Clin Oncol 2015 33 3269 76 10.1200/JCO.2015.61.2929 Open DOISearch in Google Scholar

5. Mazeron JJ, Ardiet JM, Haie-Méder C, Kovács Gy, Levendag P, Peiffert D, et al. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 2009; 91: 150–6. doi: 10.1016/j.radonc.2009.01.005 MazeronJJ ArdietJM Haie-MéderC KovácsGy LevendagP PeiffertD GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas Radiother Oncol 2009 91 150 6 10.1016/j.radonc.2009.01.005 Open DOISearch in Google Scholar

6. Ivaldi E, Di Mario D, Paderno A, Piazza C, Bossi P, Nicola Alessandro, et al. Postoperative radiotherapy (PORT) for early oral cavity cancer (pT1-2, N0-1): A review. Crit Rev Oncol Hematol 2019; 143: 67–75. doi: 10.1016/j.critrevonc.2019.08.003 IvaldiE Di MarioD PadernoA PiazzaC BossiP NicolaAlessandro Postoperative radiotherapy (PORT) for early oral cavity cancer (pT1-2, N0-1): A review Crit Rev Oncol Hematol 2019 143 67 75 10.1016/j.critrevonc.2019.08.003 Open DOISearch in Google Scholar

7. Potharaju M, E Raj H, Muthukumaran M, Venkataraman M, IIangovan B, Kupussam S, et al. Long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer. J Contemp Brachytherapy 2018; 10: 64–72. PMID: 29619058 PotharajuM E RajH MuthukumaranM VenkataramanM IIangovanB KupussamS Long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer J Contemp Brachytherapy 2018 10 64 72 29619058 Search in Google Scholar

8. Aaboubout Y, Van der Toom QM, de Ridder MAJ, Herdt MJ, Van der Steen B, Van Lanschot GC, et al. Is the depth of invasion a marker for elective neck dissection in early oral squamous cell carcinoma? Front Oncol 2021; 11: 628320. doi: 10.3389/fonc.2021.628320 AabouboutY Van der ToomQM de RidderMAJ HerdtMJ Van der SteenB Van LanschotGC Is the depth of invasion a marker for elective neck dissection in early oral squamous cell carcinoma? Front Oncol 2021 11 628320 10.3389/fonc.2021.628320 Open DOISearch in Google Scholar

9. Sternick ES, editor. The theory and practice of intensity modulated radiation therapy. 1st edition. Madison WI: Advanced Medical Publishing; 1997. SternickES editor. The theory and practice of intensity modulated radiation therapy 1st edition Madison WI Advanced Medical Publishing 1997 Search in Google Scholar

10. Grégoire V, De Neve W, Eisbruch A, Lee N, Van den Weyngaert, Van Gestel D, et al. Intensity-modulated radiation therapy for head and neck carcinoma. Oncologist 2007; 12: 555–64. doi: 10.1634/theoncologist.12-5-555 GrégoireV De NeveW EisbruchA LeeN Van den Weyngaert Van GestelD Intensity-modulated radiation therapy for head and neck carcinoma Oncologist 2007 12 555 64 10.1634/theoncologist.12-5-555 Open DOISearch in Google Scholar

11. Yu CX, Li XA, Ma L, Chen D, Naqvi S, Shepard D, et al. Clinical implementation of intensity-modulated arc therapy. Int J Radiat Oncol Biol Phys 2002; 53: 453–63. doi: 10.1016/s0360-3016(02)02777-3 YuCX LiXA MaL ChenD NaqviS ShepardD Clinical implementation of intensity-modulated arc therapy Int J Radiat Oncol Biol Phys 2002 53 453 63 10.1016/s0360-3016(02)02777-3 Open DOISearch in Google Scholar

12. Osborn J. Is VMAT beneficial for patients undergoing radiotherapy to the head and neck? Radiography 2017; 23: 73–6. doi: 10.1016/j.radi.2016.08.008 OsbornJ Is VMAT beneficial for patients undergoing radiotherapy to the head and neck? Radiography 2017 23 73 6 10.1016/j.radi.2016.08.008 Open DOISearch in Google Scholar

13. Adler JR, Cox RS. Preliminary experience with CyberKnife - Radiosurgery. Basel: S. Karger; 1996. p. 112–38. AdlerJR CoxRS Preliminary experience with CyberKnife - Radiosurgery Basel S. Karger 1996 112 38 Search in Google Scholar

14. Kurup G. CyberKnife: a new paradigm in radiotherapy. J Med Phys 2010; 35: 63–4. doi: 10.4103/0971-6203.62194 KurupG CyberKnife: a new paradigm in radiotherapy J Med Phys 2010 35 63 4 10.4103/0971-6203.62194 Open DOISearch in Google Scholar

15. Takácsi-Nagy Z, Ferenczi Ö, Major T, Akiyama H, Fröhlich G, Ferenc O, et al. Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1-2 tongue tumours. Strahlenther Onkol 2022; 198: 812–9. doi: 10.1007/s00066-022-01901-w Takácsi-NagyZ FerencziÖ MajorT AkiyamaH FröhlichG FerencO Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1-2 tongue tumours Strahlenther Onkol 2022 198 812 9 10.1007/s00066-022-01901-w Open DOISearch in Google Scholar

16. Santos M, Guinot JL, Tortajada M, Vendrell JB, López C, La Rosa A, et al. Is perioperative brachytherapy effective in carcinoma of the tongue? J Contemp Brachytherapy 2022; 14: 23–8. doi: 10.5114/jcb.2022.113425 SantosM GuinotJL TortajadaM VendrellJB LópezC La RosaA Is perioperative brachytherapy effective in carcinoma of the tongue? J Contemp Brachytherapy 2022 14 23 8 10.5114/jcb.2022.113425 Open DOISearch in Google Scholar

17. Erickson BA, Demanes DJ, Ibbott GS, Hayes JK, Hsu ICJ, Morris DE, et al. American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2011; 79: 641–9. doi: 10.1016/j.ijrobp.2010.08.046 EricksonBA DemanesDJ IbbottGS HayesJK HsuICJ MorrisDE American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 2011 79 641 9 10.1016/j.ijrobp.2010.08.046 Open DOISearch in Google Scholar

18. Yamazaki H, Yoshida K, Yoshioka Y, Shimizutani K, Furukawa S, Koizumi M, et al. High dose rate brachytherapy for oral cancer. J Radiat Res 2013; 54: 1–17. doi: 10.1093/jrr/rrs103 YamazakiH YoshidaK YoshiokaY ShimizutaniK FurukawaS KoizumiM High dose rate brachytherapy for oral cancer J Radiat Res 2013 54 1 17 10.1093/jrr/rrs103 Open DOISearch in Google Scholar

19. Union for International Cancer Control, UICC. TNM classification of malignant tumours. 8th Edition. Brierley JD, Gospodarowicz MK, Wittekind C, editors. Wiley Blackwell; 2017. Union for International Cancer Control, UICC TNM classification of malignant tumours 8th Edition BrierleyJD GospodarowiczMK WittekindC editors. Wiley Blackwell 2017 Search in Google Scholar

20. Baltas D, Kolotas C, Geramani K, Mould RF, Ioannidis G, Kekchidi M, et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 1998; 40: 515–24. doi: 10.1016/s0360-3016(97)00732-3 BaltasD KolotasC GeramaniK MouldRF IoannidisG KekchidiM A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy Int J Radiat Oncol Biol Phys 1998 40 515 24 10.1016/s0360-3016(97)00732-3 Open DOISearch in Google Scholar

21. ICRU Report 83, Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Onkol 2012; 188: 97–9. doi: 10.1007/s00066-011-0015-x. ICRU Report 83, Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT) Strahlenther Onkol 2012 188 97 9 10.1007/s00066-011-0015-x Open DOISearch in Google Scholar

22. Major T, Fröhlich G, Ágoston P, Polgár Cs, Takácsi-Nagy Z. The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry. Strahlenther Onkol 2022; 198: 93–109. doi: 10.1007/s00066-021-01867-1 MajorT FröhlichG ÁgostonP PolgárCs Takácsi-NagyZ The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry Strahlenther Onkol 2022 198 93 109 10.1007/s00066-021-01867-1 Open DOISearch in Google Scholar

23. Petera J, Sirák I, Laco J, Kašaová L, Tuček L, Doležalová H, et al. High-dose-rate brachytherapy in early oral cancer with close or positive margins. Brachytherapy 2015; 14: 77–83. doi: 10.1016/j.brachy.2014.08.050 PeteraJ SirákI LacoJ KašaováL TučekL DoležalováH High-dose-rate brachytherapy in early oral cancer with close or positive margins Brachytherapy 2015 14 77 83 10.1016/j.brachy.2014.08.050 Open DOISearch in Google Scholar

24. NCCN Clinical Practice Guidelines in Oncology. NCCN Guidelines Version 2.2023, Head and neck cancers. [cited 2023 Apr 15]. Available at: www.nccn.org/guidelines/guidelines-detail?category=1&id=1437 NCCN Clinical Practice Guidelines in Oncology NCCN Guidelines Version 2.2023, Head and neck cancers [cited 2023 Apr 15]. Available at: www.nccn.org/guidelines/guidelines-detail?category=1&id=1437 Search in Google Scholar

25. Sresty NVNM, Ramanjappa T, Raju AK, Muralidhar KR, Sudarshan G, et al. Acquisition of equal or better planning results with interstitial brachytherapy when compared with intensity-modulated radiotherapy in tongue cancers. Brachytherapy 2010; 9: 235–8. doi: 10.1016/j.brachy.2009.05.006 SrestyNVNM RamanjappaT RajuAK MuralidharKR SudarshanG Acquisition of equal or better planning results with interstitial brachytherapy when compared with intensity-modulated radiotherapy in tongue cancers Brachytherapy 2010 9 235 8 10.1016/j.brachy.2009.05.006 Open DOISearch in Google Scholar

26. Yoshida K, Takenaka T, Akiyama H, Yamazaki H, Yoshida M, Masui K, et al. Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer. J Radiat Res 2014; 55: 154–61. doi: 10.1093/jrr/rrt079 YoshidaK TakenakaT AkiyamaH YamazakiH YoshidaM MasuiK Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer J Radiat Res 2014 55 154 61 10.1093/jrr/rrt079 Open DOISearch in Google Scholar

27. Akiyama H, Pesznyák C, Béla D, Ferenczi Ö, Major T, Polgár Cs, et al. Image guided high-dose-rate brachytherapy versus volumetric modulated arc therapy for head and neck cancer: a comparative analysis of dosimetry for target volume and organs at risk. Radiol Oncol 2018; 52: 461–7. doi: 10.2478/raon-2018-0042 AkiyamaH PesznyákC BélaD FerencziÖ MajorT PolgárCs Image guided high-dose-rate brachytherapy versus volumetric modulated arc therapy for head and neck cancer: a comparative analysis of dosimetry for target volume and organs at risk Radiol Oncol 2018 52 461 7 10.2478/raon-2018-0042 Open DOISearch in Google Scholar

28. Kubota H, Miyawaki D, Mukumoto N, Ishihara T, Matsumura M, Hasegawa T, et al. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma. Radiat Oncol 2021; 16: 1. doi: 10.1186/s13014-020-01701-5 KubotaH MiyawakiD MukumotoN IshiharaT MatsumuraM HasegawaT Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma Radiat Oncol 2021 16 1 10.1186/s13014-020-01701-5 Open DOISearch in Google Scholar

29. Peterson DE, Doerr W, Hovan A, Pinto A, Saunders D, Elting LS, et al. Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies. Support Care Cancer 2010; 18: 1089–98. doi: 10.1007/s00520-010-0898-6 PetersonDE DoerrW HovanA PintoA SaundersD EltingLS Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies Support Care Cancer 2010 18 1089 98 10.1007/s00520-010-0898-6 Open DOISearch in Google Scholar

30. Swain M, Ghosh-Laskar S. Stereotactic body radiotherapy (SBRT) for primary non-metastatic head and neck cancer: when less is enough. Oral Oncol 2021; 116: 105265. doi: 10.1016/j.oraloncology.2021.105265 SwainM Ghosh-LaskarS Stereotactic body radiotherapy (SBRT) for primary non-metastatic head and neck cancer: when less is enough Oral Oncol 2021 116 105265 10.1016/j.oraloncology.2021.105265 Open DOISearch in Google Scholar

31. Jánváry ZL, Ferenczi Ö, Takácsi-Nagy Z, Bajcsay A, Polgár Cs, et al. Application of CyberKnife stereotactic radiosurgery in the treatment of head and neck cancer. Magy Onkol 2018; 62: 180–5. JánváryZL FerencziÖ Takácsi-NagyZ BajcsayA PolgárCs Application of CyberKnife stereotactic radiosurgery in the treatment of head and neck cancer Magy Onkol 2018 62 180 5 Search in Google Scholar

32. Biau J, Thivat E, Millardet C, Saroul N, Pham-Dang N, Molnar I, et al. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial. BMC Cancer 2020; 20: 730. doi: 10.1186/s12885-020-07231-3 BiauJ ThivatE MillardetC SaroulN Pham-DangN MolnarI A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial BMC Cancer 2020 20 730 10.1186/s12885-020-07231-3 Open DOISearch in Google Scholar

33. Kim MS, Malik NH, Chen H, Poon I, Husain Z, Eskander A, et al. Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review. Head and Neck 2022; 44: 770–82. doi: 10.1002/hed.26948 KimMS MalikNH ChenH PoonI HusainZ EskanderA Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review Head and Neck 2022 44 770 82 10.1002/hed.26948 Open DOISearch in Google Scholar

34. Zhang Y, Chiu T, Dubas J, Tian Z, Lee P, Gu X, et al. Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning. Radiat Oncol 2019; 14: 193. doi: 10.1186/s13014-019-1404-z ZhangY ChiuT DubasJ TianZ LeeP GuX Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning Radiat Oncol 2019 14 193 10.1186/s13014-019-1404-z Open DOISearch in Google Scholar

35. Owosho AA, Thor M, Oh JH, Riaz N, Tsai CJ, Rosenberg H, et al. The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines. J Craniomaxillofac Surg 2017; 45: 595–600. doi: 10.1016/j.jcms.2017.01.020 OwoshoAA ThorM OhJH RiazN TsaiCJ RosenbergH The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines J Craniomaxillofac Surg 2017 45 595 600 10.1016/j.jcms.2017.01.020 Open DOISearch in Google Scholar